Bio-Rad Laboratories, Inc. (BIO) vs DENTSPLY SIRONA Inc. (XRAY)

BIO leads on 7 of 13 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — BIO vs XRAY

growth of $100 · last 30y
BIO +1488.6%XRAY +44.6%BIO compounded faster
Log scale — wide-divergence pair
101001k10kStart $100200120062011201620212026$1,589$145
BIO XRAY

BIO vs XRAY: by the numbers

  • BIO is the larger company ($7.73B vs $2.02B market cap).
  • BIO is profitable (6.52% net margin) while XRAY runs a net loss (-17.06%).
  • XRAY grew revenue faster over the past five years (1.12% vs -0.84% CAGR).
  • XRAY pays a dividend (4.76% yield) while BIO does not currently pay one.

Which is better, BIO or XRAY?

Metric tally: BIO 7 · XRAY 6

It depends on what you're optimizing for:

GrowthXRAY(faster 5Y revenue CAGR)
QualityXRAY(higher ROIC)

Valuation

MetricBIOXRAY
P/E ratio47.11
Forward P/E28.697.11
P/S ratio2.980.55
P/B ratio1.131.53
EV / EBITDA18.27
FCF yield4.63%5.16%

Profitability

MetricBIOXRAY
Gross margin51.87%48.93%
Operating margin9.25%5.87%
Net margin6.52%-17.06%
ROE2.46%-47.65%
ROIC2.04%5.67%

Dividends

MetricBIOXRAY
Dividend yield4.76%

Growth (annualized)

MetricBIOXRAY
Revenue CAGR (5Y)-0.84%1.12%
EPS CAGR (5Y)-26.27%-0.93%
FCF CAGR (5Y)-7.57%-29.96%
Total return CAGR (5Y)-13.82%-29.72%

Frequently asked

Which is better, BIO or XRAY?
It depends on your goal. growth: XRAY (faster 5Y revenue CAGR); quality: XRAY (higher ROIC). Across all compared metrics, BIO leads 7 to 6.
Which has grown faster, BIO or XRAY?
Over the past five years, XRAY grew revenue faster — BIO at a -0.84% CAGR versus XRAY at 1.12%.
Does BIO or XRAY pay a bigger dividend?
XRAY pays a dividend (4.76% yield) while BIO does not currently pay one.
Is BIO or XRAY more profitable?
BIO runs the higher net margin — BIO at 6.52% versus XRAY at -17.06%.
Which has been the better investment, BIO or XRAY?
Over the past 10-year, BIO delivered the higher annualized total return — BIO at 6.91% versus XRAY at -15.61%. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.